Serologicals Corporation Schedules Second Quarter Earnings Release and Conference Call
July 20 2005 - 9:00AM
Business Wire
Serologicals Corporation (NASDAQ:SERO) announced today that it will
release its first quarter earnings on Wednesday, July 27, 2005
after the close of regular trading hours, and then host a
conference call on Thursday, July 28, 2005 at 9:00 a.m. (ET) to
review the results. The conference call dial in number is
888-291-9234, International dial-in 617-614-3923, confirmation code
67045571. The live broadcast will also be available online at the
Company's website at www.serologicals.com and at
www.StreetEvents.com. If you are unable to participate in the call,
a 14-day playback will start July 28, 2005 at 11:00 a.m. (Eastern
Time). To listen to the playback, please call 888-286- 8010,
International dial-in 617-801-6888, and enter access code 14006006,
or access the archived web cast on the Company's website at
www.serologicals.com. Serologicals Corporation (NASDAQ:SERO),
headquartered in Atlanta, GA., is a global leader in developing and
commercializing consumable biological products, enabling
technologies and services in support of biological research, drug
discovery, and the bioprocessing of life- enhancing products. Our
customers include researchers at major life science companies and
leading research institutions involved in key disciplines, such as
neurology, oncology, hematology, immunology, cardiology,
proteomics, infectious diseases, cell signaling and stem cell
research. In addition, Serologicals is the world's leading provider
of monoclonal antibodies for the blood typing industry.
Serologicals employs a total of more than 1,000 people worldwide in
three Serologicals' companies: Chemicon International,
headquartered in Temecula, CA, Upstate Group, LLC, headquartered in
Charlottesville, VA. and Celliance Corporation, headquartered in
Atlanta, GA. Serologicals is a registered trademark of Serologicals
Investment Company.
Serologicals (NASDAQ:SERO)
Historical Stock Chart
From Jul 2024 to Aug 2024
Serologicals (NASDAQ:SERO)
Historical Stock Chart
From Aug 2023 to Aug 2024